Protocol
09-108
Full Title
Percutaneous Renal Tumor Cryoablation Followed by Biopsy
Purpose
The purpose of this study is to evaluate the effectiveness of percutaneous cryoablation for freezing kidney cancers. Cryoablation works by creating freezing temperatures with a needle probe inserted through the skin. When this probe is inserted into a tumor, the freezing temperatures are used to try to kill the cancer.
Researchers want to learn how well cryoablation destroys renal cancers. They will follow patients every five to seven months after the procedure to assess the therapy’s effectiveness.
Investigator
Eligibility
To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have a renal cancer 3 cm or less in diameter.
- The tumor must be in a location that can accessed by the probe without endangering adjacent structures.
- Patients must have recovered from the side effects of any prior therapies.
- Patients must be willing and able to undergo imaging and percutaneous biopsy at five-to-seven month intervals for two years, and then at the discretion of the patient’s physician(s).
For more information and to inquire about eligibility for this study, please contact Dr. Stephen Solomon at 212-639-6610.
Disease(s)
Kidney Cancer
Locations
ClinicalTrials.gov
Related Diseases
